Oncology & Cancer
Added corticosteroid deemed ineffective for cancer pain
(HealthDay)—The addition of methylprednisolone (MP) to opioid therapy does not appear to increase the analgesic effect for cancer pain, according to research published online July 7 in the Journal of Clinical Oncology.
Jul 16, 2014
0
0
